Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Wegovy (semaglutide) is a prescription medicine indicated for chronic weight management in overweight and obese adults, as well as obese pediatric patients aged 12 years and up 1
The cash pay figures represent average pricing from major telehealth providers, while insurance costs include copays, deductibles, and required additional services
Participants receiving retatrutide 12 mg weekly achieved an average weight loss of 24.2% of body weight at 48 weeks the largest weight reduction recorded for any anti-obesity medication to date
Risk Factors Risk can be measured in several ways
In research environments, it may be used to prepare or dilute compounds under sterile conditions, or in procedures where maintaining sterility and inhibiting microbial growth are important